Patents by Inventor Jin Ok HAM

Jin Ok HAM has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CRYSTALLINE FORM II OF MELANOCORTIN RECEPTOR AGONIST COMPOUND AND PREPARATION METHOD THEREFOR
    Publication number: 20240051944
    Abstract: The present invention relates to a crystalline form II represented by formula 1, a method for preparing the same, and a pharmaceutical composition comprising the same. The crystalline form II represented by formula 1 of the present invention may be characterized by XRPD patterns, DSC profiles, TGA profiles, and/or DVS profiles.
    Type: Application
    Filed: December 22, 2021
    Publication date: February 15, 2024
    Applicant: LG CHEM, LTD.
    Inventors: Ji Yoon KIM, Ho Yeon LEE, Jin Ok HAM, Seul Ah CHUN, Sung Won KIM
  • CRYSTALLINE FORM I OF MELANOCORTIN RECEPTOR AGONIST COMPOUND AND METHOD FOR PREPARING SAME
    Publication number: 20240043407
    Abstract: The present invention relates to a crystalline form I represented by formula 1, a method for preparing the same, and a pharmaceutical composition comprising the same. The crystalline form I represented by formula 1 of the present invention may be characterized by XRPD patterns, DSC profiles, TGA profiles, and/or DVS profiles.
    Type: Application
    Filed: December 22, 2021
    Publication date: February 8, 2024
    Applicant: LG CHEM, LTD.
    Inventors: Ji Yoon KIM, Sang Dae LEE, Ri Ra KIM, Sung Won KIM, Ho Yeon LEE, Seul Ah CHUN, Jin Ok HAM
  • CRYSTALLINE FORM IV OF MELANOCORTIN RECEPTOR AGONIST COMPOUND AND PREPARATION METHOD THEREFOR
    Publication number: 20240010633
    Abstract: The present invention relates to a crystalline form IV represented by formula 1, a method for preparing the same, and a pharmaceutical composition comprising the same. The crystalline form IV represented by formula 1 of the present invention may be characterized by XRD patterns, DSC profiles, and/or TGA profiles.
    Type: Application
    Filed: October 29, 2021
    Publication date: January 11, 2024
    Applicant: LG CHEM, LTD.
    Inventors: Jin Ok HAM, Ho Yeon LEE, Ji Yoon KIM, Sung Won KIM, Seul Ah CHUN, Sang Dae LEE, Jong Won PARK
  • METHOD FOR PREPARING INTERMEDIATE FOR SYNTHESIS OF SPHINGOSINE-1-PHOSPHATE RECEPTOR AGONIST
    Publication number: 20240002322
    Abstract: The present invention relates to a novel method for producing an intermediate expressed by chemical formula 5 that can be effectively used in synthesis of sphingosine-1-phosphate receptor agonist.
    Type: Application
    Filed: October 12, 2021
    Publication date: January 4, 2024
    Applicant: LG CHEM, LTD.
    Inventors: Sung Wook KIM, Ki Dae KIM, Soo Min LEE, Ho Yeon LEE, Jin Ok HAM
  • CRYSTALLINE FORM II OF MELANOCORTIN RECEPTOR AGONIST COMPOUND AND PREPARATION METHOD THEREFOR
    Publication number: 20230399321
    Abstract: The present invention relates to a crystalline form II represented by formula 1, a method for preparing the same, and a pharmaceutical composition comprising the same. The crystalline form II represented by formula 1 of the present invention may be characterized by XRD patterns, DSC profiles, and/or TGA profiles.
    Type: Application
    Filed: October 29, 2021
    Publication date: December 14, 2023
    Applicant: LG CHEM, LTD.
    Inventors: Jin Ok HAM, Ho Yeon LEE, Ji Yoon KIM, Sung Won KIM, Seul Ah CHUN, Sang Dae LEE, Jong Won PARK
  • CRYSTALLINE FORM III OF MELANOCORTIN RECEPTOR AGONIST COMPOUND AND PREPARATION METHOD THEREFOR
    Publication number: 20230382895
    Abstract: The present invention relates to a crystalline form III represented by formula 1, a method for preparing the same, and a pharmaceutical composition comprising the same. The crystalline form III represented by formula 1 of the present invention may be characterized by XRD patterns, DSC profiles, and/or TGA profiles.
    Type: Application
    Filed: October 29, 2021
    Publication date: November 30, 2023
    Applicant: LG CHEM, LTD.
    Inventors: Jin Ok HAM, Ho Yeon LEE, Ji Yoon KIM, Sung Won KIM, Seul Ah CHUN, Sang Dae LEE, Jong Won PARK
  • CRYSTALLINE FORM I OF MELANOCORTIN RECEPTOR AGONIST COMPOUND AND PREPARATION METHOD THEREFOR
    Publication number: 20230373984
    Abstract: The present invention relates to a crystalline form I represented by formula 1, a method for preparing the same, and a pharmaceutical composition comprising the same. The crystalline form I represented by formula 1 of the present invention may be characterized by XRD patterns, DSC profiles, and/or TGA profiles.
    Type: Application
    Filed: October 29, 2021
    Publication date: November 23, 2023
    Applicant: LG CHEM, LTD.
    Inventors: Jin Ok HAM, Ho Yeon LEE, Ji Yoon KIM, Sung Won KIM, Seul Ah CHUN, Sang Dae LEE, Jong Won PARK